Response to Carifi et al.'s Letter

Abstract

Get full access to this article

View all access options for this article.

References

Yang

C.S.

, Hung

K.C.

, Huang

Y.M.

, and Hsu

W.M.

Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. J. Ocul. Pharmacol. Ther., 29:550–555, 2013.

Arevalo

J.F.

, Wu

, Sanchez

J.G.

, et al. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye., 23:117–123, 2009.

Doft

B.H.

, and Blankenship

G.W.

Single vs multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology., 89:772–779, 1982.